港股通医药ETF：9月23日融资净买入137.79万元，连续3日累计净买入374.65万元

Core Insights - The Hong Kong Stock Connect Pharmaceutical ETF (513200) experienced a net financing purchase of 1.3779 million yuan on September 23, 2025, with a financing balance of 24.2013 million yuan, indicating a positive investor sentiment towards the market [1][3]. Financing Activity Summary - On September 23, 2025, the financing buy amounted to 24.642 million yuan, while financing repayment was 23.2641 million yuan, resulting in a net financing purchase of 1.3779 million yuan [1]. - Over the past three trading days, the cumulative net financing purchase reached 3.7465 million yuan, with 11 out of the last 20 trading days showing net financing purchases [1]. - The financing balance increased by 6.04% from the previous day, reflecting a growing interest from investors [3][4]. Daily Financing Data - On September 22, 2025, the net financing purchase was 1.4602 million yuan, with a financing balance of 22.8234 million yuan [2]. - On September 19, 2025, the net financing purchase was 0.9084 million yuan, with a financing balance of 21.3632 million yuan [2]. - The financing balance on September 18, 2025, was 20.4548 million yuan, with a net financing purchase of 1.5705 million yuan [2]. Market Sentiment Analysis - An increase in financing balance indicates a bullish market sentiment, suggesting that investors are leaning towards buying [5].